-
1
-
-
85024387670
-
Fine-mapping infammatory bowel disease loci to single-variant resolution
-
Huang H, Fang M, Jostins L, et al. Fine-mapping infammatory bowel disease loci to single-variant resolution. Nature 2017;547:173-8.
-
(2017)
Nature
, vol.547
, pp. 173-178
-
-
Huang, H.1
Fang, M.2
Jostins, L.3
-
2
-
-
79959216005
-
Genetics and pathogenesis of infammatory bowel disease
-
Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of infammatory bowel disease. Nature 2011;474:307-17.
-
(2011)
Nature
, vol.474
, pp. 307-317
-
-
Khor, B.1
Gardet, A.2
Xavier, R.J.3
-
3
-
-
84975221149
-
Microbiota-inducible innate immune, Siderophore Binding Protein lipocalin 2 is critical for intestinal Homeostasis
-
Singh V, Yeoh BS, Chassaing B, et al. Microbiota-inducible innate immune, Siderophore Binding Protein lipocalin 2 is critical for intestinal Homeostasis. Cell Mol Gastroenterol Hepatol 2016;2:482-98.
-
(2016)
Cell Mol Gastroenterol Hepatol
, vol.2
, pp. 482-498
-
-
Singh, V.1
Yeoh, B.S.2
Chassaing, B.3
-
4
-
-
84944447464
-
Proneness of tlr5 defcient mice to develop colitis is microbiota dependent
-
Singh V, Yeoh BS, Carvalho F, et al. Proneness of tlr5 defcient mice to develop colitis is microbiota dependent. Gut Microbes 2015;6:279-83.
-
(2015)
Gut Microbes
, vol.6
, pp. 279-283
-
-
Singh, V.1
Yeoh, B.S.2
Carvalho, F.3
-
5
-
-
84859862381
-
Cytosolic fagellin receptor nlrc4 protects mice against mucosal and systemic challenges
-
Carvalho FA, Nalbantoglu I, Aitken JD, et al. Cytosolic fagellin receptor nlrc4 protects mice against mucosal and systemic challenges. Mucosal Immunol 2012;5:288-98.
-
(2012)
Mucosal Immunol
, vol.5
, pp. 288-298
-
-
Carvalho, F.A.1
Nalbantoglu, I.2
Aitken, J.D.3
-
6
-
-
84857049212
-
Interleukin-1β (il-1β) promotes susceptibility of toll-like receptor 5 (tlr5) defcient mice to colitis
-
Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, et al. Interleukin-1β (il-1β) promotes susceptibility of toll-like receptor 5 (tlr5) defcient mice to colitis. Gut 2012;61:373-84.
-
(2012)
Gut
, vol.61
, pp. 373-384
-
-
Carvalho, F.A.1
Nalbantoglu, I.2
Ortega-Fernandez, S.3
-
7
-
-
77956128040
-
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the nlrP3 infammasome
-
Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the nlrP3 infammasome. Gut 2010;59:1192-9.
-
(2010)
Gut
, vol.59
, pp. 1192-1199
-
-
Bauer, C.1
Duewell, P.2
Mayer, C.3
-
8
-
-
77950002937
-
The nlrP3 infammasome protects against loss of epithelial integrity and mortality during experimental colitis
-
Zaki MH, Boyd KL, Vogel P, et al. The nlrP3 infammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91.
-
(2010)
Immunity
, vol.32
, pp. 379-391
-
-
Zaki, M.H.1
Boyd, K.L.2
Vogel, P.3
-
9
-
-
77952303410
-
The nlrP3 infammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
-
Allen IC, Tekippe EM, Woodford RM, et al. The nlrP3 infammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010;207:1045-56.
-
(2010)
J Exp Med
, vol.207
, pp. 1045-1056
-
-
Allen, I.C.1
Tekippe, E.M.2
Woodford, R.M.3
-
10
-
-
85006152635
-
Nlrp3 infammasome has a protective effect against oxazolone-induced colitis: A possible role in ulcerative colitis
-
Itani S, Watanabe T, Nadatani Y, et al. Nlrp3 infammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep 2016;6:39075.
-
(2016)
Sci Rep
, vol.6
, pp. 39075
-
-
Itani, S.1
Watanabe, T.2
Nadatani, Y.3
-
11
-
-
85027693631
-
The Pathogenic role of nlrP3 infammasome activation in infammatory bowel diseases of both mice and humans
-
Liu L, Dong Y, Ye M, et al. The Pathogenic role of nlrP3 infammasome activation in infammatory bowel diseases of both mice and humans. J Crohns Colitis 2017;11:737-50.
-
(2017)
J Crohns Colitis
, vol.11
, pp. 737-750
-
-
Liu, L.1
Dong, Y.2
Ye, M.3
-
12
-
-
84906247578
-
Infammasome activation has an important role in the development of spontaneous colitis
-
Zhang J, Fu S, Sun S, et al. Infammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol 2014;7:1139-50.
-
(2014)
Mucosal Immunol
, vol.7
, pp. 1139-1150
-
-
Zhang, J.1
Fu, S.2
Sun, S.3
-
13
-
-
85019583462
-
Activation of nlrP3 infammasome in infammatory Bowel Disease: Differences between Crohn's Disease and Ulcerative colitis
-
Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ, et al. Activation of nlrP3 infammasome in infammatory Bowel Disease: Differences Between crohn's Disease and Ulcerative colitis. Dig Dis Sci 2017;62:2348-56.
-
(2017)
Dig Dis Sci
, vol.62
, pp. 2348-2356
-
-
Lazaridis, L.D.1
Pistiki, A.2
Giamarellos-Bourboulis, E.J.3
-
14
-
-
85018784717
-
Anti-infammatory effect of il-10 mediated by metabolic reprogramming of macrophages
-
Ip WKE, Hoshi N, Shouval DS, et al. Anti-infammatory effect of il-10 mediated by metabolic reprogramming of macrophages. Science 2017;356:513-9.
-
(2017)
Science
, vol.356
, pp. 513-519
-
-
Ip, W.K.E.1
Hoshi, N.2
Shouval, D.S.3
-
15
-
-
84924356420
-
The ketone metabolite β-hydroxybutyrate blocks nlrP3 infammasome-mediated infammatory disease
-
Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks nlrP3 infammasome-mediated infammatory disease. Nat Med 2015;21:263-9.
-
(2015)
Nat Med
, vol.21
, pp. 263-269
-
-
Youm, Y.H.1
Nguyen, K.Y.2
Grant, R.W.3
-
16
-
-
85014089976
-
Β-Hydroxybutyrate Deactivates neutrophil nlrP3 infammasome to relieve gout Flares
-
Goldberg EL, Asher JL, Molony RD, et al. Β-Hydroxybutyrate Deactivates neutrophil nlrP3 infammasome to relieve gout Flares. Cell Rep 2017;18:2077-87.
-
(2017)
Cell Rep
, vol.18
, pp. 2077-2087
-
-
Goldberg, E.L.1
Asher, J.L.2
Molony, R.D.3
-
17
-
-
84855382568
-
Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated tHP-1 cells
-
Ohira H, Fujioka Y, Katagiri C, et al. Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated tHP-1 cells. J Clin Biochem Nutr 2012;50:59-66.
-
(2012)
J Clin Biochem Nutr
, vol.50
, pp. 59-66
-
-
Ohira, H.1
Fujioka, Y.2
Katagiri, C.3
-
18
-
-
12244256841
-
Butyrate modulates intestinal epithelial cell-mediated neutrophil migration
-
Böcker U, Nebe T, Herweck F, et al. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol 2003;131:53-60.
-
(2003)
Clin Exp Immunol
, vol.131
, pp. 53-60
-
-
Böcker, U.1
Nebe, T.2
Herweck, F.3
-
19
-
-
85014556268
-
Inhibition of nlrP3 infammasome pathway by butyrate improves corneal wound healing in corneal alkali burn
-
Bian F, Xiao Y, Zaheer M, et al. Inhibition of nlrP3 infammasome pathway by butyrate improves corneal wound healing in corneal alkali burn. Int J Mol Sci 2017;18:562.
-
(2017)
Int J Mol Sci
, vol.18
, pp. 562
-
-
Bian, F.1
Xiao, Y.2
Zaheer, M.3
-
20
-
-
12444332013
-
Topical butyrate improves effcacy of 5-aSa in refractory distal ulcerative colitis: Results of a multicentre trial
-
Vernia P, Annese V, Bresci G, et al. Topical butyrate improves effcacy of 5-aSa in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003;33:244-8.
-
(2003)
Eur J Clin Invest
, vol.33
, pp. 244-248
-
-
Vernia, P.1
Annese, V.2
Bresci, G.3
-
21
-
-
0036212170
-
Butyrate inhibits nF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis
-
Lührs H, Gerke T, Müller JG, et al. Butyrate inhibits nF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002;37:458-66.
-
(2002)
Scand J Gastroenterol
, vol.37
, pp. 458-466
-
-
Lührs, H.1
Gerke, T.2
Müller, J.G.3
-
22
-
-
0034007264
-
Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: Randomized, double-blind, placebo-controlled pilot study
-
Vernia P, Monteleone G, Grandinetti G, et al. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci 2000;45:976-81.
-
(2000)
Dig Dis Sci
, vol.45
, pp. 976-981
-
-
Vernia, P.1
Monteleone, G.2
Grandinetti, G.3
-
23
-
-
85026922078
-
Sodium butyrate inhibits the nF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an il-10 independent manner
-
Lee C, Kim BG, Kim JH, et al. Sodium butyrate inhibits the nF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an il-10 independent manner. Int Immunopharmacol 2017;51:47-56.
-
(2017)
Int Immunopharmacol
, vol.51
, pp. 47-56
-
-
Lee, C.1
Kim, B.G.2
Kim, J.H.3
-
24
-
-
0029797691
-
Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial
-
Steinhart AH, Hiruki T, Brzezinski A, et al. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 1996;10:729-36.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 729-736
-
-
Steinhart, A.H.1
Hiruki, T.2
Brzezinski, A.3
-
25
-
-
84973666361
-
The colonic crypt protects stem cells from microbiota-derived metabolites
-
Kaiko GE, Ryu SH, Koues OI, et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 2016;165:1708-20.
-
(2016)
Cell
, vol.165
, pp. 1708-1720
-
-
Kaiko, G.E.1
Ryu, S.H.2
Koues, O.I.3
-
26
-
-
84973342043
-
Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
-
Zhang Q, Wu Y, Wang J, et al. Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium. Sci Rep 2016;6:27572.
-
(2016)
Sci Rep
, vol.6
, pp. 27572
-
-
Zhang, Q.1
Wu, Y.2
Wang, J.3
-
27
-
-
84878715402
-
Dietary choice affects Shiga toxin-producing Escherichia coli (Stec) O157:H7 colonization and disease
-
Zumbrun SD, Melton-Celsa AR, Smith MA, et al. Dietary choice affects Shiga toxin-producing escherichia coli (Stec) O157:H7 colonization and disease. Proc Natl Acad Sci USA 2013;110:e2126-e2133.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. e2126-e2133
-
-
Zumbrun, S.D.1
Melton-Celsa, A.R.2
Smith, M.A.3
-
28
-
-
85038876729
-
Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring il-22-mediated colonic health
-
Zou J, Chassaing B, Singh V, et al. Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring il-22-mediated colonic health. Cell Host Microbe 2018;23:41-53.
-
(2018)
Cell Host Microbe
, vol.23
, pp. 41-53
-
-
Zou, J.1
Chassaing, B.2
Singh, V.3
-
29
-
-
0036773030
-
Genetic control of il-1beta bioactivity through differential regulation of the il-1 receptor antagonist
-
Vamvakopoulos J, Green C, Metcalfe S. Genetic control of il-1beta bioactivity through differential regulation of the il-1 receptor antagonist. Eur J Immunol 2002;32:2988-96.
-
(2002)
Eur J Immunol
, vol.32
, pp. 2988-2996
-
-
Vamvakopoulos, J.1
Green, C.2
Metcalfe, S.3
-
30
-
-
85020038610
-
Induction of immune gene expression and infammatory mediator release by commonly used surgical suture materials: An experimental in vitro study
-
Lock AM, Gao R, Naot D, et al. Induction of immune gene expression and infammatory mediator release by commonly used surgical suture materials: an experimental in vitro study. Patient Saf Surg 2017;11:16.
-
(2017)
Patient Saf Surg
, vol.11
, pp. 16
-
-
Lock, A.M.1
Gao, R.2
Naot, D.3
-
31
-
-
45449085405
-
Pro-infammatory disequilibrium of the il-1 beta/il-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia
-
Girard S, Kadhim H, Larouche A, et al. Pro-infammatory disequilibrium of the il-1 beta/il-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008;43:54-62.
-
(2008)
Cytokine
, vol.43
, pp. 54-62
-
-
Girard, S.1
Kadhim, H.2
Larouche, A.3
-
32
-
-
36849000520
-
Deletion of tlr5 results in spontaneous colitis in mice
-
Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of tlr5 results in spontaneous colitis in mice. J Clin Invest 2007;117:3909-21.
-
(2007)
J Clin Invest
, vol.117
, pp. 3909-3921
-
-
Vijay-Kumar, M.1
Sanders, C.J.2
Taylor, R.T.3
-
33
-
-
84980335892
-
Bifdobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut
-
Rivière A, Selak M, Lantin D, et al. Bifdobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 2016;7:979.
-
(2016)
Front Microbiol
, vol.7
, pp. 979
-
-
Rivière, A.1
Selak, M.2
Lantin, D.3
-
34
-
-
58849136151
-
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMaPs) improves abdominal symptoms in patients with infammatory bowel disease-a pilot study
-
Gearry RB, Irving PM, Barrett JS, et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMaPs) improves abdominal symptoms in patients with infammatory bowel disease-a pilot study. J Crohns Colitis 2009;3:8-14.
-
(2009)
J Crohns Colitis
, vol.3
, pp. 8-14
-
-
Gearry, R.B.1
Irving, P.M.2
Barrett, J.S.3
-
35
-
-
21044435580
-
Personal view: Food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMaP hypothesis
-
Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to crohn's disease. the FODMaP hypothesis. Aliment Pharmacol Ther 2005;21:1399-409.
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 1399-1409
-
-
Gibson, P.R.1
Shepherd, S.J.2
-
36
-
-
0033046843
-
Inulin and oligofructose: Safe intakes and legal status
-
Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr 1999;129:1412S-7.
-
(1999)
J Nutr
, vol.129
, pp. 1412S-1417S
-
-
Coussement, P.A.1
-
37
-
-
84963621752
-
Follow-up of patients with functional bowel symptoms treated with a low FODMaP diet
-
Maagaard L, Ankersen D V, Végh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMaP diet. World J Gastroenterol 2016;22:4009-19.
-
(2016)
World J Gastroenterol
, vol.22
, pp. 4009-4019
-
-
Maagaard, L.1
Ankersen, D.V.2
Végh, Z.3
-
38
-
-
76149141784
-
Evidence-based dietary management of functional gastrointestinal symptoms: The FODMaP approach
-
Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMaP approach. J Gastroenterol Hepatol 2010;25:252-8.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 252-258
-
-
Gibson, P.R.1
Shepherd, S.J.2
-
39
-
-
84904752002
-
Ketone body therapy: From the ketogenic diet to the oral administration of ketone ester
-
Hashim SA, Vanitallie TB. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res 2014;55:1818-26.
-
(2014)
J Lipid Res
, vol.55
, pp. 1818-1826
-
-
Hashim, S.A.1
Vanitallie, T.B.2
-
40
-
-
33746377279
-
Regulatory t cells suppress systemic and mucosal immune activation to control intestinal infammation
-
Izcue A, Coombes JL, Powrie F. Regulatory t cells suppress systemic and mucosal immune activation to control intestinal infammation. Immunol Rev 2006;212:256-71.
-
(2006)
Immunol Rev
, vol.212
, pp. 256-271
-
-
Izcue, A.1
Coombes, J.L.2
Powrie, F.3
-
41
-
-
84994631224
-
Prevalence of infammatory Bowel Disease among adults aged ≥18 Years-United States, 2015
-
Dahlhamer JM, Zammitti E P, Ward BW, et al. Prevalence of infammatory Bowel Disease among adults aged ≥18 Years-United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1166-9.
-
(2016)
MMWR Morb Mortal Wkly Rep
, vol.65
, pp. 1166-1169
-
-
Dahlhamer, J.M.1
Zammitti, E.P.2
Ward, B.W.3
-
42
-
-
84866549438
-
Dysfunction of the intestinal microbiome in infammatory bowel disease and treatment
-
Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in infammatory bowel disease and treatment. Genome Biol 2012;13:r79.
-
(2012)
Genome Biol
, vol.13
, pp. r79
-
-
Morgan, X.C.1
Tickle, T.L.2
Sokol, H.3
-
43
-
-
84893029775
-
Increased proportions of Bifdobacterium and the lactobacillus group and loss of butyrate-producing bacteria in infammatory bowel disease
-
Wang W, Chen L, Zhou R, et al. Increased proportions of Bifdobacterium and the lactobacillus group and loss of butyrate-producing bacteria in infammatory bowel disease. J Clin Microbiol 2014;52:398-406.
-
(2014)
J Clin Microbiol
, vol.52
, pp. 398-406
-
-
Wang, W.1
Chen, L.2
Zhou, R.3
-
44
-
-
79955579989
-
The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon
-
Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011;13:517-26.
-
(2011)
Cell Metab
, vol.13
, pp. 517-526
-
-
Donohoe, D.R.1
Garge, N.2
Zhang, X.3
-
45
-
-
84890550163
-
Metabolites produced by commensal bacteria promote peripheral regulatory t-cell generation
-
Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory t-cell generation. Nature 2013;504:451-5.
-
(2013)
Nature
, vol.504
, pp. 451-455
-
-
Arpaia, N.1
Campbell, C.2
Fan, X.3
-
46
-
-
84890564250
-
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells
-
Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells. Nature 2013;504:446-50.
-
(2013)
Nature
, vol.504
, pp. 446-450
-
-
Furusawa, Y.1
Obata, Y.2
Fukuda, S.3
-
47
-
-
84881068658
-
The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis
-
Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 2013;341:569-73.
-
(2013)
Science
, vol.341
, pp. 569-573
-
-
Smith, P.M.1
Howitt, M.R.2
Panikov, N.3
-
48
-
-
77954907393
-
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
-
Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 1366-1373
-
-
Ong, D.K.1
Mitchell, S.B.2
Barrett, J.S.3
-
49
-
-
84894254680
-
Wild-type and il10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifdobacterium animalis subspecies lactis and inulin
-
Kuo SM, Chan WC, Hu Z. Wild-type and il10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifdobacterium animalis subspecies lactis and inulin. J Nutr 2014;144:245-51.
-
(2014)
J Nutr
, vol.144
, pp. 245-251
-
-
Kuo, S.M.1
Chan, W.C.2
Hu, Z.3
-
50
-
-
53049093860
-
Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse
-
Misikangas M, Tanayama H, Rajakangas J, et al. Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse. Br J Nutr 2008;99:963-70.
-
(2008)
Br J Nutr
, vol.99
, pp. 963-970
-
-
Misikangas, M.1
Tanayama, H.2
Rajakangas, J.3
-
51
-
-
0041464523
-
Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice
-
Pajari AM, Rajakangas J, Päivärinta E, et al. Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int J Cancer 2003;106:653-60.
-
(2003)
Int J Cancer
, vol.106
, pp. 653-660
-
-
Pajari, A.M.1
Rajakangas, J.2
Päivärinta, E.3
-
52
-
-
84962022192
-
Chronically elevated levels of short-chain fatty acids induce t cell-mediated ureteritis and hydronephrosis
-
Park J, Goergen CJ, Hogenesch H, et al. Chronically elevated levels of short-chain fatty acids induce t cell-mediated ureteritis and hydronephrosis. J Immunol 2016;196:2388-400.
-
(2016)
J Immunol
, vol.196
, pp. 2388-2400
-
-
Park, J.1
Goergen, C.J.2
Hogenesch, H.3
-
53
-
-
84922163095
-
Short-chain fatty acids induce both effector and regulatory t cells by suppression of histone deacetylases and regulation of the mtOr-S6K pathway
-
Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory t cells by suppression of histone deacetylases and regulation of the mtOr-S6K pathway. Mucosal Immunol 2015;8:80-93.
-
(2015)
Mucosal Immunol
, vol.8
, pp. 80-93
-
-
Park, J.1
Kim, M.2
Kang, S.G.3
-
54
-
-
85021290293
-
Supplementation of low-and high-fat diets with fermentable fber exacerbates severity of DSS-induced acute colitis
-
Miles J P, Zou J, Kumar M V, et al. Supplementation of low-and high-fat diets with fermentable fber exacerbates severity of DSS-induced acute colitis. Infamm Bowel Dis 2017;23:1133-43.
-
(2017)
Infamm Bowel Dis
, vol.23
, pp. 1133-1143
-
-
Miles, J.P.1
Zou, J.2
Kumar, M.V.3
-
55
-
-
0030703162
-
Metronidazole. a therapeutic review and update
-
Freeman CD, Klutman NE, Lamp KC. Metronidazole. a therapeutic review and update. Drugs 1997;54:679-708.
-
(1997)
Drugs
, vol.54
, pp. 679-708
-
-
Freeman, C.D.1
Klutman, N.E.2
Lamp, K.C.3
|